Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150051610> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2150051610 endingPage "206" @default.
- W2150051610 startingPage "199" @default.
- W2150051610 abstract "NADPH oxidase was originally identified in immune cells as playing an important microbicidal role. In neurodegenerative and cerebrovascular diseases, inflammation is increasingly being recognized as contributing negatively to neurological outcome, with NADPH-oxidase as an important source of superoxide. Recently, several forms of this oxidase have been found in a variety of non-immune cells. Neuronal NADPH oxidase is thought to participate in longterm potentiation and intercellular signaling. However, excessive superoxide production is damaging and has been shown to play an important role in the progression of brain injury. NADPH oxidase is a multisubunit complex composed of membrane-associated gp91phox and p22phox subunits and cytosolic subunits, p47phox, p67phox, and p40phox and Rac. When NADPH oxidase is activated through phosphorylatoin of p47phox, cytosolic subunits translocate to the cell membrane and fuse with the catalytic subunit, gp91phox. The activated enzyme complex transports electrons to oxygen, thus producing the superoxide anion (O2 – ), a precursor of reactive oxygen species. The advantage of a targeted NADPH oxidase inhibitor that would inhibit the production of superoxide non-phagocytic cells is clear. To date no such therapeutically viable inhibitor exists but recent research using current inhibitors has enhanced our knowledge of the role of NADPH oxidase in CNS diseases and provides impetus to develop a very specific, potent and safe NADPH oxidase inhibitor." @default.
- W2150051610 created "2016-06-24" @default.
- W2150051610 creator A5016571028 @default.
- W2150051610 creator A5043729394 @default.
- W2150051610 creator A5052775902 @default.
- W2150051610 creator A5059839352 @default.
- W2150051610 date "2012-02-01" @default.
- W2150051610 modified "2023-09-23" @default.
- W2150051610 title "NOX Inhibitors as a Therapeutic Strategy for Stroke and Neurodegenerative Disease" @default.
- W2150051610 doi "https://doi.org/10.2174/138945012799201676" @default.
- W2150051610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22204319" @default.
- W2150051610 hasPublicationYear "2012" @default.
- W2150051610 type Work @default.
- W2150051610 sameAs 2150051610 @default.
- W2150051610 citedByCount "29" @default.
- W2150051610 countsByYear W21500516102012 @default.
- W2150051610 countsByYear W21500516102013 @default.
- W2150051610 countsByYear W21500516102014 @default.
- W2150051610 countsByYear W21500516102015 @default.
- W2150051610 countsByYear W21500516102016 @default.
- W2150051610 countsByYear W21500516102017 @default.
- W2150051610 countsByYear W21500516102019 @default.
- W2150051610 countsByYear W21500516102020 @default.
- W2150051610 countsByYear W21500516102021 @default.
- W2150051610 countsByYear W21500516102022 @default.
- W2150051610 countsByYear W21500516102023 @default.
- W2150051610 crossrefType "journal-article" @default.
- W2150051610 hasAuthorship W2150051610A5016571028 @default.
- W2150051610 hasAuthorship W2150051610A5043729394 @default.
- W2150051610 hasAuthorship W2150051610A5052775902 @default.
- W2150051610 hasAuthorship W2150051610A5059839352 @default.
- W2150051610 hasConcept C181199279 @default.
- W2150051610 hasConcept C185592680 @default.
- W2150051610 hasConcept C2777209548 @default.
- W2150051610 hasConcept C2779719074 @default.
- W2150051610 hasConcept C2780795997 @default.
- W2150051610 hasConcept C2781308076 @default.
- W2150051610 hasConcept C38485361 @default.
- W2150051610 hasConcept C48349386 @default.
- W2150051610 hasConcept C55493867 @default.
- W2150051610 hasConcept C79879829 @default.
- W2150051610 hasConcept C86803240 @default.
- W2150051610 hasConcept C95444343 @default.
- W2150051610 hasConcept C98539663 @default.
- W2150051610 hasConceptScore W2150051610C181199279 @default.
- W2150051610 hasConceptScore W2150051610C185592680 @default.
- W2150051610 hasConceptScore W2150051610C2777209548 @default.
- W2150051610 hasConceptScore W2150051610C2779719074 @default.
- W2150051610 hasConceptScore W2150051610C2780795997 @default.
- W2150051610 hasConceptScore W2150051610C2781308076 @default.
- W2150051610 hasConceptScore W2150051610C38485361 @default.
- W2150051610 hasConceptScore W2150051610C48349386 @default.
- W2150051610 hasConceptScore W2150051610C55493867 @default.
- W2150051610 hasConceptScore W2150051610C79879829 @default.
- W2150051610 hasConceptScore W2150051610C86803240 @default.
- W2150051610 hasConceptScore W2150051610C95444343 @default.
- W2150051610 hasConceptScore W2150051610C98539663 @default.
- W2150051610 hasIssue "2" @default.
- W2150051610 hasLocation W21500516101 @default.
- W2150051610 hasLocation W21500516102 @default.
- W2150051610 hasOpenAccess W2150051610 @default.
- W2150051610 hasPrimaryLocation W21500516101 @default.
- W2150051610 hasRelatedWork W1532150676 @default.
- W2150051610 hasRelatedWork W1973953924 @default.
- W2150051610 hasRelatedWork W1989994240 @default.
- W2150051610 hasRelatedWork W2019036639 @default.
- W2150051610 hasRelatedWork W2043614277 @default.
- W2150051610 hasRelatedWork W2061598305 @default.
- W2150051610 hasRelatedWork W2075401573 @default.
- W2150051610 hasRelatedWork W2765229711 @default.
- W2150051610 hasRelatedWork W3194454364 @default.
- W2150051610 hasRelatedWork W990413323 @default.
- W2150051610 hasVolume "13" @default.
- W2150051610 isParatext "false" @default.
- W2150051610 isRetracted "false" @default.
- W2150051610 magId "2150051610" @default.
- W2150051610 workType "article" @default.